List
The Award database is continually updated throughout the year. As a result, data for FY19 is not expected to be complete until April, 2020.
-
DEVELOPMENT OF A DIFFERENTIAL GPS NAVIGATION FILTER WITH AUTONOMOUS FAILURE DETECTION
SBC: NAVSYS CORPORATION, THE Topic: N/AN/A
SBIR Phase I 1990 Department of Transportation -
HIGH RESOLUTION SOIL WATER CONTENT PROFILING
SBC: Intercomp Topic: N/AWE PROPOSE TO DEVELOP A SIMPLE TO USE, QUANTITATIVE DEVICE TO ACCURATELY MEASURE SOIL WATER CONTENT WITH SUFFICIENT RESOLUTION TO DEFINE WETTING FRONTS DUE TO RAIN EVENTS IN DEPTH PROFILES. THIS GEOPHYSICAL TOOL SENSES CHANGE IN THE ELECTROMAGNETIC ENVIRONMENT, SPECIFICALLY THE DIELECTRIC CONSTANT OF THE SOIL, WHICH IS DIRECTLY RELATED TO SOIL WATER CONTENT. THE SOIL WATER CONTENT PROFILING DEVICE ...
SBIR Phase II 1990 Department of Agriculture -
FIELD INSTRUMENT FOR WIND ERODED SOIL MASS
SBC: Sensit Company Topic: N/AWITHIN THE CRYSTAL UPON THE PARTICLE'S COLLISON. THE SENSORHAS BEEN DESIGNED TO RESPOND TO THE MOMENTUM RANGE OF 2.6 X 10 -12 TO 8.9 X 10 -7 G-M/S. THIS CORRESPONDS TO PARTI-CLES HAVING A DIAMETER RANGE OF 100 TO 1500 MICROMETERS TRAVELING AT VELOCITIES OF 2.0 TO 20 M/S, THE MAIN CONSTITU-ENT OF WIND ERODED SOIL. CALIBRATION OF THE SENSOR OVER THIS MOMENTUM RANGE UTILIZING ASSORTED SIZED PARTICLES ...
SBIR Phase II 1990 Department of Agriculture -
DEVELOPMENT OF A LOW COST ETHYLENE OXIDE DETECTOR
SBC: ADA Technologies, Inc. Topic: N/ATHE OBJECTIVE OF THIS RESEARCH PROGRAM IS TO DEMONSTRATE THE FEASIBILITY AND DEVELOP TOWARDS COMMERCIALIZATION A LOW-COST, RELIABLE DETECTOR TO MONITOR ETHYLENE OXIDE (ETO) DOWN TO THE 0.1 PPM LEVEL. THE DETECTOR WOULD HAVE A RESPONSE TIME OF ONE MINUTE OR LESS AND WOULD FEATURE A GAS CHROMATOGRAPH (GC) COLUMN COUPLED WITH A SOLID STATE COMBUSTIBLE GAS SENSOR. AIR DRAWN AS PART OF THE SAMPLE WOULD ...
SBIR Phase II 1990 Department of Health and Human Services -
DEVELOPMENT OF A LOW-COST ETHYLENE OXIDE DETECTOR
SBC: ADA Technologies, Inc. Topic: N/AN/A
SBIR Phase II 1990 Department of Health and Human Services -
CHROMIUM DEFICIENCY IN INSULIN RESISTANCE
SBC: ATOM SCIENCES, INC. Topic: N/ACHROMIUM DEFICIENCY CAUSES SEVERE INSULIN RESISTANCE AND GLUCOSE INTOLERANCE. AVERAGE DIETARY CHROMIUM INTAKE IN THEUNITED STATES AND OTHER DEVELOPED COUNTRIES IS MARGINAL AND MAY CONTRIBUTE TO THE HIGH FREQUENCY OF DIABETES PLAGUING DEVELOPED COUNTRIES. THE MAJOR CLINICAL CHROMIUM EVALUATIONPROBLEM IS THE ASSESSMENT OF CHROMIUM STATUS. DETERMINATIONOF CHROMIUM STATUS HAS BEEN DIFFICULT BECAUSE OF ...
SBIR Phase II 1990 Department of Health and Human Services -
A BIODEGRADABLE, INJECTABLE DELIVERY SYSTEM FOR NSAIDS
SBC: ATRIX LABORATORIES, INC. Topic: N/AIN THIS RESEARCH, NSAIDS WILL BE INDIVIDUALLY INCORPORATED INTO A DELIVERY SYSTEM. THE IN VITRO DELIVERY RATES WILL BEDETERMINED, AND THEN THE SYSTEM OPTIMIZED TO OBTAIN IN VITRO DELIVERY RATES OF 1 TO 12 WEEKS. THE VARIABLES THAT WILL BE EXAMINED TO OPTIMIZE RELEASE ARE POLYMER TYPE AND MOLECULAR WEIGHT, DRUG LOADING, AND BIOCOMPATIBLE PLASTICIZER CONTENT. FIVE NSAIDS WILL BE INDIVIDUALLY EVALUAT ...
SBIR Phase I 1990 Department of Health and Human Services -
N/A
SBC: ATRIX LABORATORIES, INC. Topic: N/AN/A
SBIR Phase I 1990 Department of Health and Human Services -
FULL-LENGTH, FIBEROPTIC ESOPHAGEAL PRESSURE MONITOR
SBC: Begej Corp. Topic: N/ATHE OVERALL GOAL OF THIS PROJECT IS TO DEVELOP AN INNOVATIVE, FULL-LENGTH, FIBEROPTIC ESOPHAGEAL PRESSURE-MONITORING INSTRUMENT. THIS DEVICE WILL CONTRIBUTETO IMPROVED HEALTH CARE BY OFFERING SIGNIFICANTLY ENHANCED PERFORMANCE AND LOWER COST OVER CURRENT METHODS OF CHARACTERIZING PATHOLOGICAL BEHAVIOR OF THE ESOPHAGUS AND RELATED ORGANS. THE IMMEDIATE GOALS OF THE PHASE I PROJECT ARE TO DEMONSTRAT ...
SBIR Phase I 1990 Department of Health and Human Services -
OPTICAL ASSAY FOR MEASURING COLLAGENASE IN GCF
SBC: Biostar Medical Products, Inc Topic: N/ATHIS PROJECT WILL DEVELOP A RAPID ASSAY FOR MEASURING COLLAGENASE ACTIVITY IN GINGIVAL CREVICULAR FLUID (GCF) TO DIAGNOSE PERIODONTAL DISEASE, WHICH IS VERY PREVALENT IN THE U.S. POPULATION, AFFECTING UP TO 75 PERCENT OF ADULTS. MOST DIAGNOSTIC TECHNIQUES AVAILABLE TO CLINICIANS CANNOT PREDICT FUTURE ATTACHMENT LOSS. COLLAGENASE IN GCF IS AN IMPORTANT MARKER OF DISEASE ACTIVITY, BUT PREVIOUS METHO ...
SBIR Phase I 1990 Department of Health and Human Services